Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen vs Anastrozole +/- Zoledronic Acid in Premenopausal HR+ Breast Cancer
NCT00295646Phase 3Completed
- Sponsor
- Austrian Breast and Colorectal Cancer Study Group
- Start
- Jun 1999
- Primary completion
- Mar 2008
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of anastrozole, tamoxifen, zoledronic acid in breast cancer, sponsored by Austrian Breast and Colorectal Cancer Study Group. Started Jun 1999; status: completed.
02
Drugs
anastrozoletamoxifenzoledronic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00295646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00295646.